Literature DB >> 17085806

Quantitative assay for mouse atherosclerosis in the aortic root.

Julie Baglione1, Jonathan D Smith.   

Abstract

The mouse has become the preferred species for genetic manipulation aimed at creating and studying models for human disease. Although mice are highly resistant to atherosclerosis, dietary induction and, more frequently, gene knockout and transgenic mice have been widely used to study factors that alter the susceptibility to atherosclerosis. Although there are several ways to assess atherosclerosis in mice, measurement of the aortic root lesion area is a commonly used, medium-throughput method that allows for histological examination of the lesions. Here, we provide the detailed methods for the quantitative analysis of mouse aortic root lesion area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085806     DOI: 10.1385/1-59745-213-0:83

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  32 in total

1.  Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Zhe Dong; Tingting Wu; Weidong Qin; Chuankai An; Zhihao Wang; Mingxiang Zhang; Yun Zhang; Cheng Zhang; Fengshuang An
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.

Authors:  Min Zhu; Qing-Jun Zhang; Lin Wang; Hao Li; Zhi-Ping Liu
Journal:  Atherosclerosis       Date:  2011-10-02       Impact factor: 5.162

3.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

4.  Chronic intermittent electronic cigarette exposure induces cardiac dysfunction and atherosclerosis in apolipoprotein-E knockout mice.

Authors:  Jorge Espinoza-Derout; Kamrul M Hasan; Xuesi M Shao; Maria C Jordan; Carl Sims; Desean L Lee; Satyesh Sinha; Zena Simmons; Norma Mtume; Yanjun Liu; Kenneth P Roos; Amiya P Sinha-Hikim; Theodore C Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-07       Impact factor: 4.733

5.  Confirmation of Ath26 locus on chromosome 17 and identification of Cyp4f13 as an atherosclerosis modifying gene.

Authors:  Juying Han; Peggy Robinet; Brian Ritchey; Heather Andro; Jonathan D Smith
Journal:  Atherosclerosis       Date:  2019-05-09       Impact factor: 5.162

6.  Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus.

Authors:  Daniel E Venegas-Pino; Nicole Banko; Mohammed I Khan; Yuanyuan Shi; Geoff H Werstuck
Journal:  J Vis Exp       Date:  2013-12-07       Impact factor: 1.355

7.  Sex Differences in the LDL Receptor Knockout Mouse Model of Atherosclerosis.

Authors:  Neel A Mansukhani; Zheng Wang; Vera P Shively; Megan E Kelly; Janet M Vercammen; Melina R Kibbe
Journal:  Artery Res       Date:  2017-09-21       Impact factor: 0.597

8.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

9.  Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Authors:  Reema Goel; Benjamin R Schrank; Shikha Arora; Brian Boylan; Barbara Fleming; Hiroto Miura; Peter J Newman; Robert C Molthen; Debra K Newman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

10.  Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice.

Authors:  Zhenglong Wang; Bei Liu; Ping Wang; Xuemei Dong; Carlos Fernandez-Hernando; Zhong Li; Timothy Hla; Zihai Li; Kevin Claffey; Jonathan D Smith; Dianqing Wu
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.